AKTX   $4.47  -3.87% Market Closed

Akari Therapeutics Plc

EMA (20): 2026-02-27 the price crossed down the moving average line and formed a short-term downside trend.

EMA (50): 2025-10-15 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2025-10-10 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in overbought territory and it falls. These factors indicate that perhaps the upside trend is coming to an end. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the negative territory it's higher than the signal line and falls. These factors mean that negative mood prevails, but this trend does not have a significant strength. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

Trend Type flat and down
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -2.62%
EMA (20) date of signal Feb. 27, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -71.95%
EMA (50) date of signal Oct. 15, 2025, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -75.27%
EMA (100) date of signal Oct. 10, 2025, 3 a.m.
RSI Signals bearish
RSI (14) Yield -2.62%
RSI (14) date of signal Feb. 27, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -2.62%
MACD date of signal Feb. 27, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -2.62%
Stochastic date of signal Feb. 27, 2026, 3 a.m.
Updated March 4, 2026, 8:06 p.m.